An interventional study of The Blank Center CARE Model(TM) for Individuals who Stutter in Stuttering, Stuttering, Adult and Stuttering, Childhood, sponsored by University of Texas at Austin. Recruiting at 1 site in United States. Open to participants aged 2 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-22.
Sponsored by University of Texas at Austin · Not applicable, Interventional, and Treatment
Among 35 studies in Stuttering with a site in United States — 17 open to participants now, 18 under way, none of them phase 3. Stuttering · United States.
Among the 35 studies in Stuttering with a site in United States, this one has the largest planned enrollment of the 27 interventional ones, is the only one that started in 2015, is one of 18 with no phase, reaches primary completion later than 17 of the 17 other live ones, and was the 21st registered.
74 studies on the registry are indexed under Stuttering; 23 are open to participants now.
This study's planned enrollment of 3,000 is above the median of 44 across 57 interventional studies indexed under Stuttering.
Browse Stuttering studies →17 of the 35 studies in Stuttering with a site in United States are open now, in 1 country. Each count lists the studies.
Of the 19 Stuttering studies recruiting now, 3 (16%) set no upper age limit and 15 (79%) stop at 75 or younger; 6 take children under 18; 9 take healthy volunteers.
This study: 2 Years to 85 Years · all sexes · healthy volunteers too.
The full table on the hub →35 studies; the count open now beside each. This study's row is marked.
First in 1992; this study’s year is marked. 1 started in 2015.
Median enrollment 68 across the 27 interventional studies, 411 across the 7 observational. Of the 14 that completed or were terminated, 3 (21%) have results posted.
3 of 35 have an industry lead sponsor. The 10 most frequent:
University of Texas at Austin is the lead sponsor of 328 studies on the registry; 79 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.
University of Texas at Austin has 1 study filed under Stuttering — fewer than ten, so there is no comparison to draw.
6 of the studies in Stuttering with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07354139The University of Texas at DallasUsing Non-invasive Brain Stimulation to Explore Potential Treatments to Reduce Speech Errors in Adults Who Stutter | 2027-02-28 |
| NCT06578416Michigan State UniversityThe Development of Stuttering in Young Children | 2027-06 |
| NCT07215884University of California, San FranciscoDopamine and Sensorimotor Function in Stuttering | 2027-06-30 |
| NCT07734103CSTrials Inc.Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder | 2027-07-31 |
| NCT07668882University of MichiganNoninvasive Thalamocortical Neuromodulation With Low-Intensity Focused Ultrasound for Persistent Developmental Stuttering | 2027-08 |
Among the 35 studies in Stuttering with a site in United States, from their registry updates:
The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training specific to fluency disorders.
Stuttering is a neurophysiological communication disorder characterized by a disruption in the forward flow of speech. Stuttering is multifactorial in nature, meaning there are several factors that likely to contribute to the development of stuttering in children and persistence of stuttering into adulthood. About 1% of the worldwide population stutters. In the United States, over 3 million people stutter. Research suggests people who stutter present with negative cognitive and affective components of the disorder, and that the general population holds negative perceptions of stuttering. Historically, people who stutter spend thousands of dollars on treatment that is not effective in mitigating the negative impact of stuttering on their overall communication and quality of life.
Speech-language pathologists evaluate and treat persons who stutter across the lifespan. Research suggests speech-language pathologists report fluency disorders (stuttering and cluttering) as the communication disorders with which they feel least competent and comfortable.
Thus, the purposes of this study are to 1) investigate potential speech, language, psychosocial, and motor contributions to stuttered speech production in monolingual and multilingual speakers and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training tools specific to fluency disorders.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
A participant will be considered a child who stutters (ages 2-17 years) if
A participant will be considered an adult who stutters (18+ years) if
Exclusion Criteria:
Behavioral: The Blank Center CARE Model(TM) for Individuals who Stutter
The over-arching goal of the Blank Center CARE Model is to ensure individuals who stutter communicate effectively, advocate for themselves in a manner that maintains agency, and ensure their quality of life does not depend on producing, or attempting to control, stuttered speech.
Also known as: Communication-Centered Treatment (CCT)
Communication Competence
psychometric measures of communication competence (e.g., CARE Assessment: Communication Subscale)
Time frame: 11-weeks
Advocacy
psychometric measures of self-advocacy (e.g., CARE Assessment: Advocacy Subscale)
Time frame: 11-weeks
Resilience
psychometric measures of resilience (e.g., CARE Assessment: Resilience Subscale)
Time frame: 11-weeks
Education
psychometric measures of education about stuttering (e.g., CARE Assessment: Education Subscale)
Time frame: 11-weeks
Plan to share: Undecided
Started May 2015 (actual). Primary completion is estimated for May 2035, 240 months after the start.
Of 37 interventional studies with no phase under Stuttering, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 38. This study's planned 240 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Texas at Austin →